FDG PET aids in assessment of outcomes in degenerative cervical myelopathy

08/15/2013 | MolecularImaging.net

Researchers utilized F-18 FDG PET to measure uptake in the spine and shed light on surgical outcomes in degenerative cervical myelopathy patients. The study conducted the scans in 20 patients with degenerative cervical stenosis before surgery and after one year. Results published in the Journal of Nuclear Medicine showed that 10 patients had substantial FDG uptake before surgery and decreased uptake at follow-up. The other 10 patients showed insignificant uptake prior to surgery and even lower levels after successful treatment.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC